Table 2.

The Management of Dyslipidemia in Adults with Chronic Kidney Disease

Dyslipidemia	Goal	Initiate	Increase	Alternative
TG ≥ 500 mg/dl	TG < 500 mg/dl	Lifestyle changes	Lifestyle changes + fibrate or niacin	Fibrate or niacin
LDL-C 100–129 mg/dl	LDL-C < 100 mg/dl	Lifestyle changes	Lifestyle changes + low-dose statin	Bile acid sequestrant or niacin
LDL-C ≥ 130 mg/dl	LDL-C < 100 mg/dl	Lifestyle changes + low-dose statin	Lifestyle changes + max-dose statin	Bile acid sequestrant or niacin
TG ≥ 200 mg/dl and non-HDL-C ≥ 130 mg/dl	Non-HDL-C < 130 mg/dl	Lifestyle changes + low-dose statin	Lifestyle changes + max-dose statin	Fibrate or niacin

HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides.

Reproduced with permission from K/DOQI guidelines on treating dyslipidemia.³